{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:02Z","timestamp":1791928682560,"version":"4.3.4"},"reference-count":76,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,6,4]]},"DOI":"10.1167\/iovs.18-24122","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T20:14:58Z","timestamp":1532117698000},"page":"AMD31","source":"Crossref","is-referenced-by-count":52,"title":["The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease"],"prefix":"10.1167","volume":"59","author":[{"given":"Christian","family":"Schori","sequence":"first","affiliation":[{"name":"Lab for Retinal Cell Biology, Department of Ophthalmology, University of Zurich, Zurich, Switzerland"},{"name":"Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trachsel","sequence":"additional","affiliation":[{"name":"Functional Genomics Center Zurich (FGCZ), ETH Zurich and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Grossmann","sequence":"additional","affiliation":[{"name":"Functional Genomics Center Zurich (FGCZ), ETH Zurich and University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Zygoula","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Barthelmes","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland"},{"name":"Save Sight Institute, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Grimm","sequence":"additional","affiliation":[{"name":"Lab for Retinal Cell Biology, Department of Ophthalmology, University of Zurich, Zurich, Switzerland"},{"name":"Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland"},{"name":"Neuroscience Center Zurich (ZNZ), University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-4-AMD31-b01","doi-asserted-by":"crossref","unstructured":"Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992; 99: 933\u2013943.","DOI":"10.1016\/S0161-6420(92)31871-8"},{"key":"i1552-5783-59-4-AMD31-b02","doi-asserted-by":"crossref","unstructured":"Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995; 102: 1450\u20131460.","DOI":"10.1016\/S0161-6420(95)30846-9"},{"key":"i1552-5783-59-4-AMD31-b03","doi-asserted-by":"crossref","unstructured":"Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995; 102: 205\u2013210.","DOI":"10.1016\/S0161-6420(95)31034-2"},{"key":"i1552-5783-59-4-AMD31-b04","doi-asserted-by":"crossref","unstructured":"Bird AC. Choroidal neovascularisation in age-related macular disease. Br J Ophthalmol. 1993; 77: 614\u2013615.","DOI":"10.1136\/bjo.77.10.614"},{"key":"i1552-5783-59-4-AMD31-b05","doi-asserted-by":"crossref","unstructured":"Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol (Chicago, Ill 1960). 1984; 102: 1640\u20131642.","DOI":"10.1001\/archopht.1984.01040031330019"},{"key":"i1552-5783-59-4-AMD31-b06","unstructured":"Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980; 24: 335\u2013610."},{"key":"i1552-5783-59-4-AMD31-b07","doi-asserted-by":"crossref","unstructured":"Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol (Chicago, Ill 1960). 1982; 100: 912\u2013918.","DOI":"10.1001\/archopht.1982.01030030920003"},{"key":"i1552-5783-59-4-AMD31-b08","doi-asserted-by":"crossref","unstructured":"Group MPS. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol (Chicago, Ill 1960). 1990; 108: 816\u2013824.","DOI":"10.1001\/archopht.1990.01070080058036"},{"key":"i1552-5783-59-4-AMD31-b09","doi-asserted-by":"crossref","unstructured":"Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol (Chicago, Ill 1960). 1993; 111: 1200\u20131209.","DOI":"10.1001\/archopht.1993.01090090052019"},{"key":"i1552-5783-59-4-AMD31-b10","doi-asserted-by":"crossref","unstructured":"Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005; 308: 421\u2013424.","DOI":"10.1126\/science.1110189"},{"key":"i1552-5783-59-4-AMD31-b11","doi-asserted-by":"crossref","unstructured":"Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005; 308: 419\u2013421.","DOI":"10.1126\/science.1110359"},{"key":"i1552-5783-59-4-AMD31-b12","doi-asserted-by":"crossref","unstructured":"Khan JC, Thurlby DA, Shahid H, et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol. 2006; 90: 75\u201380.","DOI":"10.1136\/bjo.2005.073643"},{"key":"i1552-5783-59-4-AMD31-b13","doi-asserted-by":"crossref","unstructured":"Klein BE, Klein R, Lee KE, Jensen SC. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol. 2001; 8: 251\u2013262.","DOI":"10.1076\/opep.8.4.251.1612"},{"key":"i1552-5783-59-4-AMD31-b14","doi-asserted-by":"crossref","unstructured":"Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005; 308: 385\u2013389.","DOI":"10.1126\/science.1109557"},{"key":"i1552-5783-59-4-AMD31-b15","doi-asserted-by":"crossref","unstructured":"Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol. 2003; 121: 1728\u20131737.","DOI":"10.1001\/archopht.121.12.1728"},{"key":"i1552-5783-59-4-AMD31-b16","doi-asserted-by":"crossref","unstructured":"Grunwald JE, Metelitsina TI, Dupont JC, Ying G-S, Maguire MG. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci. 2005; 46: 1033\u20131038.","DOI":"10.1167\/iovs.04-1050"},{"key":"i1552-5783-59-4-AMD31-b17","doi-asserted-by":"crossref","unstructured":"Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006; 355: 1432\u20131444.","DOI":"10.1056\/NEJMoa062655"},{"key":"i1552-5783-59-4-AMD31-b18","doi-asserted-by":"crossref","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355: 1419\u20131431.","DOI":"10.1056\/NEJMoa054481"},{"key":"i1552-5783-59-4-AMD31-b19","doi-asserted-by":"crossref","unstructured":"Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I\/II multicenter, controlled, multidose study. Ophthalmology. 2006; 113: 633.e1\u2013e4.","DOI":"10.1016\/j.ophtha.2005.10.052"},{"key":"i1552-5783-59-4-AMD31-b20","doi-asserted-by":"crossref","unstructured":"Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ; for the CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011; 364: 1897\u20131908.","DOI":"10.1056\/NEJMoa1102673"},{"key":"i1552-5783-59-4-AMD31-b21","doi-asserted-by":"crossref","unstructured":"Shitama T, Hayashi H, Noge S, et al. Proteome profiling of vitreoretinal diseases by cluster analysis. Proteomics Clin Appl. 2008; 2: 1265\u20131280.","DOI":"10.1002\/prca.200800017"},{"key":"i1552-5783-59-4-AMD31-b22","unstructured":"Wu CW, Sauter JL, Johnson PK, Chen C-D, Olsen TW. Identification and localization of major soluble vitreous proteins in human ocular tissue. Am J Ophthalmol. 2004; 137: 655\u2013661."},{"key":"i1552-5783-59-4-AMD31-b23","doi-asserted-by":"crossref","unstructured":"Gao B-BB, Chen X, Timothy N, Aiello LP, Feener EP. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res. 2008; 7: 2516\u20132525.","DOI":"10.1021\/pr800112g"},{"key":"i1552-5783-59-4-AMD31-b24","doi-asserted-by":"crossref","unstructured":"Kim T, Kim SJ, Kim K, et al. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics. 2007; 7: 4203\u20134215.","DOI":"10.1002\/pmic.200700745"},{"key":"i1552-5783-59-4-AMD31-b25","doi-asserted-by":"crossref","unstructured":"Wang H, Feng L, Hu J, Xie C, Wang F. Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry. Exp Eye Res. 2013; 108: 110\u2013119.","DOI":"10.1016\/j.exer.2012.11.023"},{"key":"i1552-5783-59-4-AMD31-b26","doi-asserted-by":"crossref","unstructured":"Murthy KR, Goel R, Subbannayya Y, et al. Proteomic analysis of human vitreous humor. Clin Proteomics. 2014; 11: 29.","DOI":"10.1186\/1559-0275-11-29"},{"key":"i1552-5783-59-4-AMD31-b27","doi-asserted-by":"crossref","unstructured":"Aretz S, Krohne TU, Kammerer K, et al. In-depth mass spectrometric mapping of the human vitreous proteome. Proteome Sci. 2013; 11: 22.","DOI":"10.1186\/1477-5956-11-22"},{"key":"i1552-5783-59-4-AMD31-b28","doi-asserted-by":"crossref","unstructured":"Angi M, Kalirai H, Coupland SE, Damato BE, Semeraro F, Romano MR. Proteomic analyses of the vitreous humour. Mediators Inflamm. 2012; 2012: 148039.","DOI":"10.1155\/2012\/148039"},{"key":"i1552-5783-59-4-AMD31-b29","doi-asserted-by":"crossref","unstructured":"Bennett KL, Funk M, Tschernutter M, et al. Proteomic analysis of human cataract aqueous humour: comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ\u00ae-labelled specimens. J Proteomics. 2011; 74: 151\u2013166.","DOI":"10.1016\/j.jprot.2010.10.002"},{"key":"i1552-5783-59-4-AMD31-b30","doi-asserted-by":"crossref","unstructured":"Pollreisz A, Funk M, Breitwieser FP, et al. Quantitative proteomics of aqueous and vitreous fluid from patients with idiopathic epiretinal membranes. Exp Eye Res. 2013; 108: 48\u201358.","DOI":"10.1016\/j.exer.2012.11.010"},{"key":"i1552-5783-59-4-AMD31-b31","doi-asserted-by":"crossref","unstructured":"Yu J, Peng R, Chen H, Cui C, Ba J. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis. Invest Ophthalmol Vis Sci. 2012; 53: 8146\u20138153.","DOI":"10.1167\/iovs.12-10079"},{"key":"i1552-5783-59-4-AMD31-b32","doi-asserted-by":"crossref","unstructured":"Nobl M, Reich M, Dacheva I, et al. Proteomics of vitreous in neovascular age-related macular degeneration. Exp Eye Res. 2016; 146: 107\u2013117.","DOI":"10.1016\/j.exer.2016.01.001"},{"key":"i1552-5783-59-4-AMD31-b33","doi-asserted-by":"crossref","unstructured":"Koss MJ, Hoffmann J, Nguyen N, et al. Proteomics of vitreous humor of patients with exudative age-related macular degeneration. PLoS One. 2014; 9: e96895.","DOI":"10.1371\/journal.pone.0096895"},{"key":"i1552-5783-59-4-AMD31-b34","doi-asserted-by":"crossref","unstructured":"Lobo A, Lightman S. Vitreous aspiration needle tap in the diagnosis of intraocular inflammation. Ophthalmology. 2003; 110: 595\u2013599.","DOI":"10.1016\/S0161-6420(02)01895-X"},{"key":"i1552-5783-59-4-AMD31-b35","doi-asserted-by":"crossref","unstructured":"Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009; 6: 359\u2013362.","DOI":"10.1038\/nmeth.1322"},{"key":"i1552-5783-59-4-AMD31-b36","doi-asserted-by":"crossref","unstructured":"K\u00e4ll L, Storey JD, MacCoss MJ, Noble WS. Assigning significance to peptides identified by tandem mass spectrometry using decoy databases. J Proteome Res. 2008; 7: 29\u201334.","DOI":"10.1021\/pr700600n"},{"key":"i1552-5783-59-4-AMD31-b37","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015; 43: D447\u2013D452.","DOI":"10.1093\/nar\/gku1003"},{"key":"i1552-5783-59-4-AMD31-b38","doi-asserted-by":"crossref","unstructured":"Rawlings ND, Barrett AJ, Finn R. Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 2016; 44: D343\u2013D350.","DOI":"10.1093\/nar\/gkv1118"},{"key":"i1552-5783-59-4-AMD31-b39","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2017."},{"key":"i1552-5783-59-4-AMD31-b40","doi-asserted-by":"crossref","unstructured":"Hulsen T, de Vlieg J, Alkema W. BioVenn: a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics. 2008; 9: 488.","DOI":"10.1186\/1471-2164-9-488"},{"key":"i1552-5783-59-4-AMD31-b41","doi-asserted-by":"crossref","unstructured":"Wang J, Vasaikar S, Shi Z, Greer M, Zhang B. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res. 2017; 45: W130\u2013W137.","DOI":"10.1093\/nar\/gkx356"},{"key":"i1552-5783-59-4-AMD31-b42","doi-asserted-by":"crossref","unstructured":"Kutmon M, Riutta A, Nunes N, et al. WikiPathways: capturing the full diversity of pathway knowledge. Nucleic Acids Res. 2016; 44: D488\u2013D494.","DOI":"10.1093\/nar\/gkv1024"},{"key":"i1552-5783-59-4-AMD31-b43","doi-asserted-by":"crossref","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102: 15545\u201315550.","DOI":"10.1073\/pnas.0506580102"},{"key":"i1552-5783-59-4-AMD31-b44","doi-asserted-by":"crossref","unstructured":"Vizca\u00edno JA, Csordas A, Del-Toro N, et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 2016; 44: D447\u2013D456.","DOI":"10.1093\/nar\/gkv1145"},{"key":"i1552-5783-59-4-AMD31-b45","doi-asserted-by":"crossref","unstructured":"Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004; 11: 67\u2013115.","DOI":"10.1076\/opep.11.2.67.28158"},{"key":"i1552-5783-59-4-AMD31-b46","doi-asserted-by":"crossref","unstructured":"Mitchell J, Bradley C. Quality of life in age-related macular degeneration: a review of the literature. Health Qual Life Outcomes. 2006; 4: 97.","DOI":"10.1186\/1477-7525-4-97"},{"key":"i1552-5783-59-4-AMD31-b47","doi-asserted-by":"crossref","unstructured":"Loukovaara S, Nurkkala H, Tamene F, et al. Quantitative proteomics analysis of vitreous humor from diabetic retinopathy patients. J Proteome Res. 2015; 14: 5131\u20135143.","DOI":"10.1021\/acs.jproteome.5b00900"},{"key":"i1552-5783-59-4-AMD31-b48","doi-asserted-by":"crossref","unstructured":"Yamane K, Minamoto A, Yamashita H, et al. Proteome analysis of human vitreous proteins. Mol Cell Proteomics. 2003; 2: 1177\u20131187.","DOI":"10.1074\/mcp.M300038-MCP200"},{"key":"i1552-5783-59-4-AMD31-b49","doi-asserted-by":"crossref","unstructured":"Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A. 2002; 99: 14682\u201314687.","DOI":"10.1073\/pnas.222551899"},{"key":"i1552-5783-59-4-AMD31-b50","doi-asserted-by":"crossref","unstructured":"Umeda S, Suzuki MT, Okamoto H, et al. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J. 2005; 19: 1683\u20131685.","DOI":"10.1096\/fj.04-3525fje"},{"key":"i1552-5783-59-4-AMD31-b51","doi-asserted-by":"crossref","unstructured":"Yuan X, Gu X, Crabb JS, et al. Quantitative proteomics: comparison of the macular Bruch membrane\/choroid complex from age-related macular degeneration and normal eyes. Mol Cell Proteomics. 2010; 9: 1031\u20131046.","DOI":"10.1074\/mcp.M900523-MCP200"},{"key":"i1552-5783-59-4-AMD31-b52","doi-asserted-by":"crossref","unstructured":"Nordgaard CL, Karunadharma PP, Feng X, Olsen TW, Ferrington DA. Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008; 49: 2848\u20132855.","DOI":"10.1167\/iovs.07-1352"},{"key":"i1552-5783-59-4-AMD31-b53","doi-asserted-by":"crossref","unstructured":"Mack A, Robitzki A. The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study. Prog Neurobiol. 2000; 60: 607\u2013628.","DOI":"10.1016\/S0301-0082(99)00047-7"},{"key":"i1552-5783-59-4-AMD31-b54","doi-asserted-by":"crossref","unstructured":"Lockridge O. Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther. 2015; 148: 34\u201346.","DOI":"10.1016\/j.pharmthera.2014.11.011"},{"key":"i1552-5783-59-4-AMD31-b55","doi-asserted-by":"crossref","unstructured":"Murthy V, Gao Y, Geng L, LeBrasseur N, White T, Brimijoin S. Preclinical studies on neurobehavioral and neuromuscular effects of cocaine hydrolase gene therapy in mice. J Mol Neurosci. 2014; 53: 409\u2013416.","DOI":"10.1007\/s12031-013-0130-5"},{"key":"i1552-5783-59-4-AMD31-b56","doi-asserted-by":"crossref","unstructured":"Jaffe EK, Martins J, Li J, Kervinen J, Dunbrack RL. The molecular mechanism of lead inhibition of human porphobilinogen synthase. J Biol Chem. 2001; 276: 1531\u20131537.","DOI":"10.1074\/jbc.M007663200"},{"key":"i1552-5783-59-4-AMD31-b57","doi-asserted-by":"crossref","unstructured":"Princ FG, Maxit AG, Cardalda C, Batlle A, Juknat AA. In vivo protection by melatonin against delta-aminolevulinic acid-induced oxidative damage and its antioxidant effect on the activity of haem enzymes. J Pineal Res. 1998; 24: 1\u20138.","DOI":"10.1111\/j.1600-079X.1998.tb00359.x"},{"key":"i1552-5783-59-4-AMD31-b58","doi-asserted-by":"crossref","unstructured":"Harris J, Schwinn N, Mahoney JA, et al. A vitellogenic-like carboxypeptidase expressed by human macrophages is localized in endoplasmic reticulum and membrane ruffles. Int J Exp Pathol. 2006; 87: 29\u201339.","DOI":"10.1111\/j.0959-9673.2006.00450.x"},{"key":"i1552-5783-59-4-AMD31-b59","doi-asserted-by":"crossref","unstructured":"Hu C, Zhang R, Yu W, et al. CPVL\/CHN2 genetic variant is associated with diabetic retinopathy in Chinese type 2 diabetic patients. Diabetes. 2011; 60: 3085\u20133089.","DOI":"10.2337\/db11-0028"},{"key":"i1552-5783-59-4-AMD31-b60","doi-asserted-by":"crossref","unstructured":"Sorrentino S. Human extracellular ribonucleases: multiplicity, molecular diversity and catalytic properties of the major RNase types. Cell Mol Life Sci. 1998; 54: 785\u2013794.","DOI":"10.1007\/s000180050207"},{"key":"i1552-5783-59-4-AMD31-b61","doi-asserted-by":"crossref","unstructured":"Fischer S, Nishio M, Dadkhahi S, et al. Expression and localisation of vascular ribonucleases in endothelial cells. Thromb Haemost. 2011; 105: 345\u2013355.","DOI":"10.1160\/TH10-06-0345"},{"key":"i1552-5783-59-4-AMD31-b62","doi-asserted-by":"crossref","unstructured":"Gansler J, Preissner KT, Fischer S. Influence of proinflammatory stimuli on the expression of vascular ribonuclease 1 in endothelial cells. FASEB J. 2014; 28: 752\u2013760.","DOI":"10.1096\/fj.13-238600"},{"key":"i1552-5783-59-4-AMD31-b63","doi-asserted-by":"crossref","unstructured":"Kvanta A. Ocular angiogenesis: the role of growth factors. Acta Ophthalmol Scand. 2006; 84: 282\u2013288.","DOI":"10.1111\/j.1600-0420.2006.00659.x"},{"key":"i1552-5783-59-4-AMD31-b64","doi-asserted-by":"crossref","unstructured":"Witmer A. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res. 2003; 22: 1\u201329.","DOI":"10.1016\/S1350-9462(02)00043-5"},{"key":"i1552-5783-59-4-AMD31-b65","doi-asserted-by":"crossref","unstructured":"Sene A, Chin-Yee D, Apte R. Seeing through VEGF: innate and adaptive immunity in pathologic angiogenesis in the eye. Trends Mol Med. 2015; 1: 43\u201351.","DOI":"10.1016\/j.molmed.2014.10.005"},{"key":"i1552-5783-59-4-AMD31-b66","doi-asserted-by":"crossref","unstructured":"Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol (Chicago, Ill 1960). 2006; 124: 995\u20131001.","DOI":"10.1001\/archopht.124.7.995"},{"key":"i1552-5783-59-4-AMD31-b67","doi-asserted-by":"crossref","unstructured":"Schick T, Ersoy L, Lechanteur YTE, et al. History of sunlight exposure is a risk factor for age-related macular degeneration. Retina. 2016; 36: 787\u2013790.","DOI":"10.1097\/IAE.0000000000000756"},{"key":"i1552-5783-59-4-AMD31-b68","doi-asserted-by":"crossref","unstructured":"Batliwala S, Xavier C, Liu Y, Wu H, Pang I. Involvement of Nrf2 in ocular diseases. Oxid Med Cell Longev. 2017; 2017: 1703810.","DOI":"10.1155\/2017\/1703810"},{"key":"i1552-5783-59-4-AMD31-b69","doi-asserted-by":"crossref","unstructured":"Datta S, Cano M, Ebrahimi K, Wang L, Handa JT. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res. 2017; 60: 201\u2013218.","DOI":"10.1016\/j.preteyeres.2017.03.002"},{"key":"i1552-5783-59-4-AMD31-b70","doi-asserted-by":"crossref","unstructured":"Mojana F, Cheng L, Bartsch DG, et al. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol. 2008; 146: 218\u2013227.","DOI":"10.1016\/j.ajo.2008.04.027"},{"key":"i1552-5783-59-4-AMD31-b71","doi-asserted-by":"crossref","unstructured":"Vall\u00e9e A, Lecarpentier Y, Guillevin R, Vall\u00e9e JN. Aerobic glycolysis hypothesis through WNT\/Beta-catenin pathway in exudative age-related macular degeneration. J Mol Neurosci. 2017; 62: 368\u2013379.","DOI":"10.1007\/s12031-017-0947-4"},{"key":"i1552-5783-59-4-AMD31-b72","doi-asserted-by":"crossref","unstructured":"Yokosako K, Mimura T, Funatsu H, et al. Glycolysis in patients with age-related macular degeneration. Open Ophthalmol J. 2014; 8: 39\u201347.","DOI":"10.2174\/1874364101408010039"},{"key":"i1552-5783-59-4-AMD31-b73","unstructured":"Niederkorn JY, Kaplan HJ. Rationale for immune response and the eye. Chem Immunol Allergy. 2007; 92: 1\u20133."},{"key":"i1552-5783-59-4-AMD31-b74","doi-asserted-by":"crossref","unstructured":"Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010; 29: 95\u2013112.","DOI":"10.1016\/j.preteyeres.2009.11.003"},{"key":"i1552-5783-59-4-AMD31-b75","unstructured":"Clark SJ, Bishop PN. The eye as a complement dysregulation hotspot. Semin Immunopathol. 2017; 84: 65\u201376."},{"key":"i1552-5783-59-4-AMD31-b76","doi-asserted-by":"crossref","unstructured":"Jha P, Bora PS, Bora NS. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol. 2007; 44: 3901\u20133908.","DOI":"10.1016\/j.molimm.2007.06.145"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2683957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:54Z","timestamp":1791927054000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,3,20]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24122","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,4]]}}}